Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney Transplant

NCT01928199 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Posttransplant Diabetes Mellitus

Interventions

DRUG: Sitagliptin
DRUG: Placebo

Sponsor

Washington University School of Medicine

Collaborators

[object Object]